Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Delcath Systems (DCTH) Research & Development (2016 - 2025)

Delcath Systems (DCTH) has 15 years of Research & Development data on record, last reported at $9.4 million in Q4 2025.

  • For Q4 2025, Research & Development rose 221.59% year-over-year to $9.4 million; the TTM value through Dec 2025 reached $29.2 million, up 110.8%, while the annual FY2025 figure was $29.2 million, 110.8% up from the prior year.
  • Research & Development reached $9.4 million in Q4 2025 per DCTH's latest filing, up from $8.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $18.1 million in Q4 2022 and bottomed at $150000.0 in Q2 2022.
  • Average Research & Development over 5 years is $5.1 million, with a median of $4.0 million recorded in 2022.
  • Peak YoY movement for Research & Development: tumbled 95.71% in 2022, then soared 2270.0% in 2023.
  • A 5-year view of Research & Development shows it stood at $3.6 million in 2021, then surged by 399.59% to $18.1 million in 2022, then tumbled by 73.95% to $4.7 million in 2023, then plummeted by 38.12% to $2.9 million in 2024, then skyrocketed by 221.59% to $9.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $9.4 million in Q4 2025, $8.0 million in Q3 2025, and $6.9 million in Q2 2025.